DEUTSCHE BANK AG\

Bank

Position in FTRE — Fortrea Holdings Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in FTRE

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$24,202,561

-$19,891,768 QoQ

Shares Held

2,569,274

+0.5% QoQ

Ownership

2.72%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. FTRE ranks #17 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,537,736	$686,660,626
2	REGN	Regeneron Pharmaceuticals, Inc.	625,388	$483,199,777
3	ALNY	Alnylam Pharmaceuticals, Inc.	761,464	$251,945,590
4	INCY	Incyte Corp	1,264,195	$118,986,027
5	RPRX	Royalty Pharma plc	2,453,303	$117,684,942
6	ARGX	Argenx SE	139,381	$101,782,972
7	INSM	INSMED Inc	562,474	$91,975,745
8	LGND	Ligand Pharmaceuticals Inc	306,111	$61,115,059

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$24,202,561	2,569,274	+0.5%	Shares	Other	2026-05-06
2025-12-31	$44,094,329	2,556,193	+0.3%	Shares	Other	2026-02-11
2025-09-30	$21,458,437	2,548,508	+56.6%	Shares	Other	2025-11-13
2025-06-30	$8,041,518	1,627,838	+39.7%	Shares	Defined	2025-08-12
2025-03-31	$8,796,399	1,165,086	+17183.6%	Shares	Other	2025-05-09
2024-12-31	$125,719	6,741	-31.9%	Shares	Other	2025-06-30
2024-09-30	$197,840	9,892	+0.5%	Shares	Other	2025-06-26
2024-06-30	$229,642	9,839	-35.5%	Shares	Other	2025-06-12
2024-03-31	$612,776	15,266	-0.5%	Shares	Defined	2025-06-02
2023-12-31	$535,609	15,347	+20.2%	Shares	Defined	2024-02-14
2023-09-30	$365,007	12,767	—	Shares	Defined	2023-11-24
No filing history on record for this holder in this stock.